{"version":"1.0","type":"link","title":"Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab.","author_name":"Nixon AB 외","author_url":"https://prs-insight.online/author/Nixon%20AB","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/138741","thumbnail_width":1200,"thumbnail_height":630}